Silvec Biologics offers therapy for trees using RNA-based molecules.
Silvec Biologics has raised $98K in total funding. The most recent round was Grant. The last funding was announced in June 2025.
Silvec Biologics's investors include National Science Foundation, Maryland Department of Commerce, Orbia Ventures, Maryland Innovation Initiative (MII).
Silvec Biologics is headquartered in Gaithersburg, United States.
Silvec Biologics offers therapy for trees using RNA-based molecules.
Silvec Biologics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Silvec Biologics — Funding & Investors." VCBacked, June 10, 2025, https://www.vcbacked.co/company/silvec-biologics. Accessed August 14, 2026.
VCBacked. (2025). Silvec Biologics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/silvec-biologics
{{cite web |title=Silvec Biologics — Funding & Investors |url=https://www.vcbacked.co/company/silvec-biologics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated